RE: So much negativity21 Sep 2021 11:59
GloriaMarket wrote
"The POC kit still doesn't work and its Q4 next week."
I find this this statement confusing and seemingly untrue. According to RNS data reports it works very well and is going through CE qualification right now.
GloriaMarket wrote
" I can't see POC selling unless its cheaper than LFTs and based on GDR's track record they price themselves out of the market."
You are missing the point with the POC. It is not a replacement for LFT. It is a far more accurate, reliable, multi-variant detection medical device for different markets. LFT is classed as mass lower accuracy rapid testing. This is why for travel only PCR or supervised LFT are acceptable. Positive LFT still normally require PCR confirmation. Genedrive COV POC is the next evolution for the more lab based PCR test e.g. a hospital ward will be able to confirm a patient is infected within minutes instead of days with the best possible accuracy. I can imagine one in every large Boots pharnacy, replacing their current Covid services through the Recova-19 PCR portal (say).
GloriaMarket wrote
"They'd initially said the POC would be saliva based and obviously its still not working so they've had to go for a nasal swab - as if the market is waiting for another nasal swab test. They know it's not, POC version one will not sell. POC version two might but that's another 18 months away at least, looking at their track record"
I don't believe this is so. Mark 1 was always to be swab and GDR had expressed their ultimate aim was to achieve bead/saliva format in Mark 2/3.
I should imagine all versions are being developed in parallel to save time. The main difference between Mark 1 and future Marks will be the assay cartridge, so should less development time spent on the actual Genedrive device itself.
You seem to have little faith in any of Genedrive's products, so find it difficult to understand why you invested at all.
However, I understand your frustration/sentiment and also agree we are not in a good place right now, but mis-information/speculation is going to do no one any favours.
The Genedrive AIHL combo should start to bring in some money within a few months. This has been developed hand-in-hand with a highly respected world renowned customer, the NHS. Once it's in their hands, it should help doors open elsewhere and more sales will (hopefully) follow.
Sign In
Follow the stocks
